⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14697526 | 0.67 | — | — | |
| SCHEMBL10478906 | 0.67 | CA1 (0.46) | — | |
| SCHEMBL3086740 | 0.67 | — | — | |
| SCHEMBL10478911 | 0.67 | CA1 (0.46) | — | |
| SCHEMBL3278397 | 0.67 | — | — | |
| Sulfamide SCHEMBL19639013 | 0.64 | — | — | |
| SCHEMBL41623 | 0.64 | — | — | |
| SCHEMBL16834201 | 0.64 | — | — | |
| SCHEMBL8995855 | 0.64 | — | — | |
| SCHEMBL15361466 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 423 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117980327-A | Specific coupling of antibodies | 杭州多禧生物科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-116710146-A | Antibody molecule-drug conjugates and uses thereof | 威特拉公司 | 2023-09-05 | — | — | CN | claimed |
| WO-2023138211-A1 | STAR-SHAPED β-ANTIBACTERIAL GLYCOPEPTIDE, PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州万维生命科学技术有限公司 | 2023-07-27 | — | — | WO | claimed |
| CN-114828860-A | Transdermal microflora preparation | 霍夫曼技术有限责任公司 | 2022-07-29 | — | — | CN | claimed |
| US-10449247-B2 | Compositions and methods for enhancing immune response | AVIVAGEN INC. (CA) | 2019-10-22 | — | — | US | claimed |
| CN-109689067-A | GLYCAN COMPOSITIONS AND METHODS OF USE | 卡莱多生物科技有限公司 | 2019-04-26 | — | — | CN | claimed |
| US-20190022274-A1 | FORMATION OF SEMI-PERMEABLE POROUS ARTIFICIAL SCAB | VEGA VILLAVICENCIO PARSIVAL (AR) | 2019-01-24 | — | — | US | claimed |
| EP-2939678-B1 | THIXOTROPIC FLUID FOR USE AS A CICATRIZING AGENT | VEGA VILLAVICENCIO PARSIVAL (AR) | 2017-04-19 | — | — | EP | claimed |
| US-20160000963-A1 | FORMATION OF SEMI-PERMEABLE POROUS ARTIFICAL SCAB | VEGA VILLAVICENCIO PARSIVAL (US) | 2016-01-07 | — | — | US | claimed |
| EP-2273989-A1 | COMBINATION THERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS | Interface Biologics Inc. (CA) | 2011-01-19 | — | — | EP | claimed |
| EP-0792371-A4 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO INC (US) | 1998-12-30 | — | — | EP | claimed |
| EP-0792371-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-09-03 | — | — | EP | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| EP-0741570-A1 | METHOD FOR PREVENTING OR REDUCING PHOTOSENSITIVITY AND/OR PHOTOTOXICITY REACTIONS TO MEDICATIONS | G.D. SEARLE & CO. (US) | 1996-11-13 | — | — | EP | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1995020387-A1 | METHOD FOR PREVENTING OR REDUCING PHOTOSENSITIVITY AND/OR PHOTOTOXICITY REACTIONS TO MEDICATIONS | G.D. SEARLE & CO. (US) | 1995-08-03 | — | — | WO | claimed |
| EP-0046270-B1 | NOVEL DERIVATIVES OF BIO-AFFECTING PHENOLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | INTERx RESEARCH CORPORATION (US) | 1986-05-21 | — | — | EP | claimed |
| EP-0046270-A1 | Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them | INTERx RESEARCH CORPORATION (US) | 1982-02-24 | — | — | EP | claimed |